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Abstract:  For  over  30  years  it  has  been  established  that  the  Entamoeba  histolytica 
protozoan included two biologically and genetically different species, one with a pathogenic 
phenotype  called  E.  histolytica  and  the  other  with  a  non-pathogenic  phenotype  called 
Entamoeba dispar. Both of these amoebae species can infect humans. E. histolytica has been 
considered  as  a  potential  pathogen  that  can  cause  serious  damage  to  the  large  intestine 
(colitis, dysentery) and other extraintestinal organs, mainly the liver (amebic liver abscess), 
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whereas  E.  dispar  is  a  species  that  interacts  with  humans in  a commensal relationship, 
causing  no  symptoms  or  any  tissue  damage.  This  paradigm,  however,  should  be 
reconsidered or re-evaluated. In the present work, we report the detection and genotyping of 
E. dispar sequences of DNA obtained from patients with amebic liver abscesses, including 
the genotyping of an isolate obtained from a Brazilian patient with a clinical diagnosis of 
intestinal amebiasis that was previously characterized as an E. dispar species. The genetic 
diversity  and phylogenetic analysis performed by our group has  shown the existence of 
several  different  genotypes  of  E.  dispar  that  can  be  associated  to,  or  be  potentiality 
responsible for intestinal or liver tissue damage, similar to that observed with E. histolytica. 
Keywords: human amebiasis; E. histolytica; E. dispar; genetic diversity; phylogeny 
 
 
1. Introduction  
 
Entamoeba  histolytica  is  the  etiological  agent  of  human  amebiasis.  The  most  common  clinical 
forms of disease are amebic colitis and amebic liver abscess. This protozoon, once considered a unique 
species  with  different  pathogenic  capabilities,  is  the  causal  agent  of  invasive  disease  (pathogenic  
E. histolytica), and under circumstances that are not well defined, is able to maintain a commensal 
behavior in the human intestine (non-pathogenic E. histolytica) [1-3]. Morphological differences, such 
as  trophozoites  and  cysts,  between  Entamoeba  dispar  and  Entamoeba  histolytica  are  nearly 
undetectable microscopically; thus, it is difficult to establish a differential diagnosis at this level. It is 
now clear that E. histolytica includes two biologically and genetically different species, one with a 
pathogenic  phenotype  called  E.  histolytica  and  the  other  with  a  non-pathogenic  phenotype  called  
E. dispar [4]. Previous to the studies that allowed the molecular characterization of both species, the 
estimations of the worldwide burden of amebiasis indicated that approximately 500 million people 
were infected by the parasite, and 10% of these individuals had invasive amebiasis. Moreover, 100,000 
patients per year had died due to the clinical complications of the disease [5]. Since the separation of 
these two species, the epidemiology of amebiasis has changed, and we are actually just at the beginning 
of re-assessing the burden of this disease [6,7]. 
Studies on the epidemiology of amebiasis in endemic areas have utilized molecular approaches to 
characterize the prevalent species of Entamoeba in specific populations and in distinct geographic 
areas.  These  studies  have  characterized  the  diverse  spectrum  of  human  host-parasite  interactions. 
Under this spectrum are the asymptomatic infections due to E. histolytica species, the asymptomatic 
infection due to E. dispar, asymptomatic mixed infections (E. histolytica + E. dispar) and symptomatic 
E.  histolytica  infections  (intestinal  or  extraintestinal  amebiasis).  Moreover,  recent  studies  on  the 
genetic  diversity  in  both  the  E.  histolytica  and  E.  dispar  species,  detected  in  infected  individuals 
presenting  with  different  outcomes  of  the  infection  (i.e.,  asymptomatic  or  invasive  disease),  has 
unveiled the extraordinary polymorphism of both Entamoeba species [8-12]. These studies analyzed 
the  coding  and  non-coding  DNA  regions  of  these  species,  allowing  a  better  understanding  of  the 
heterogeneous  character  of  the  parasite  infection  sources  as  well  as  the  complexity  of  the  human Int. J. Environ. Res. Public Health 2010, 7                 
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asymptomatic infection and the disease. Recent reports showing the differences in the genotypes of  
E. histolytica isolates from fecal samples and samples from amebic liver abscesses obtained from the 
same patient [13] and the detection of different genotypes of E. histolytica detected in a patient with 
two  simultaneous  and  independent  amebic  abscesses  of  the  liver  [14]  are  two  examples  of  this 
complexity. Several hypotheses were considered in these studies to explain the observed genotype 
variations, ranging from the ingestion of inoculums containing more than one E. histolytica and/or  
E. dispar genotypes (strains) to the possible existence of some kind of organ tropism or a possible 
recombination phenomenon during intestinal colonization.  
It  has  been  reported  that  E.  dispar  may  be  the  causative  agent  of  intestinal  symptoms  in  
humans [15-17]. Using an animal model, it has also been demonstrated that this species can cause 
tissue lesions in the intestine and serious damage to epithelial cells [18-21]. Comparative analysis of 
gene  content  between  these  two  species,  especially  those  related  to  pathogenesis  in  humans,  has 
revealed that almost the entire set of genes of E. histolytica is present in E. dispar. This includes genes 
such as Gal/GalNac-inhibitable lectin, the amebopore protein and different proteases [22]. 
In  the  present  work,  we  report  the  detection  and  genotyping  of  E.  dispar  DNA obtained from 
patients with liver abscesses (amebic or pyogenic). Furthermore, we report the genotyping of an isolate 
obtained  from  a  Brazilian  patient  clinically  diagnosed  with  non-dysenteric  amebic  colitis,  a  strain 
previously characterized as an E. dispar species using PCR [17]. The stool specimen of the patient was 
cultured in Pavlova’s medium in the presence of the original intestinal flora. Finally, the phylogenetic 
relations of the DNA sequences obtained in our study are also discussed.  
 
2. Results and Discussion  
 
2.1. Patients and Analyzed Samples 
 
Analyzed  samples  were  obtained  from  20  patients  who  were  admitted  to  the  department  of 
Infectology, General Surgery and Internal Medicine at the General Hospital from the National Health 
Ministry in Mexico City. The presumptive diagnosis during the admission in the emergency room was 
hepatic abscess of unknown etiology. The final clinical diagnosis established by the primary physician 
was supported by the laboratory findings (thoracic X-ray, hepatic ultrasound and the presence or not of 
high levels of serum anti-amebic antibodies detected using ELISA [23]). In all cases, the dimensions of 
the  abscesses  required  ultrasound-guided  drainage.  The  drained  material  was  treated  for  DNA 
extraction  and  PCR  amplification  of  polymorphic  regions  of  non-transcribed  intergenic  regions 
associated with tRNA genes using both E. histolytica and E. dispar specific primers. Six of the 20 
abscess samples consistently amplified and generated a PCR product with primer Dsp1-2 (specific for 
E. dispar species), which was similar in molecular size to the PCR product obtained with the reference 
strain E. dispar SAW760; the rest of DNA samples (14) generated PCR products in the presence of E. 
histolytica specific primers (Hsp1-2) (data not shown). The general characteristics and the relevant 
clinical findings of these six patients are shown in Table 1. Four of the six studied samples were from 
female patients (age ranging from 38 to 57 years). Samples from patients with liver abscesses that were 
PCR positive for E. dispar did not show any temporal or spatial relationship, and it can be assumed 
that infection events were independent. The levels of serum IgG anti-amebic antibodies were tested Int. J. Environ. Res. Public Health 2010, 7                 
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using ELISA technique [23]. Three of the patients infected with E. histolytica species shown high 
levels of IgG anti-amebic antibodies (patients A-69, A-92 and A-104), while in the remaining three 
were negative (patients N-49, N-61 and N-77) (Table 1). This finding is not unexpected in individuals 
infected with E. dispar species; however, we have to remark that there is not previous experience in 
antibody immune response in patients with extraintestinal E. dispar infections. On the other hand, the 
ELISA test used in the present study was designed using a membrane rich extract of E. histolytica 
HM1:IMSS trophozoites, that has proved to be highly specific in detection of anti- ameba antibodies in 
both, serum (IgG) and saliva (IgAs) samples in patients of invasive amebiasis [23]. 
As we already mentioned, we also studied the ICB-ADO strain that is an isolated from a Brazilian 
patient of non-dysenteric amebic colitis. The stool specimen of the patient was cultured in Pavlova’s 
medium and maintained in a xenic culture containing the patient’s original intestinal flora. This strain 
was previously characterized as an E. dispar species using PCR [17]. In the next sections some of the 
phenotypic characteristics of the ICB-ADO strain are described. 
The  decision  to  perform  the  PCR  with  both  sets  of  primers  was  made  based  on  our  previous 
experience [7] and that of Ali et al. (2008) [6], which suggested that the host-parasite relationship in 
humans due to E. histolytica and E. dispar infection may be more complex than previously thought.  
 
2.2. Species Description and Phylogenetic Reconstructions  
 
Using the molecular markers Dsp1-2 and Hsp1-2 the relationship of the samples was determined 
using all sequences of the intergenic region Dsp1-2 and Hsp1-2 reported in GenBank. With this data 
we performed a phylogenetic reconstruction of both E. dispar and E. histolytica, including sequences 
amplified in samples of liver abscesses. From the six sequences obtained for Dsp1-2 of liver abscess 
were included only three (A-69, A-104, N-77) and the remaining (A-92, N-49, N-61) was removed 
because they had double peaks in some positions of the sequence, which mean that more than one 
haplotype  may be present  in  the sample. These double peaks  can  also  be the consequence of  the 
existence  of  a  heterozygote  individual  or  the presence of more than one individual with  different 
genotype. The analyzed sequences, including the geographic region where the sample was obtained as 
well  as  the  type  of  sample  (i.e.,  fecal  sample,  liver  abscess,  etc.),  are  shown  in  Figure  1.  In  the 
phylogenetic  reconstruction  of  the  E.  dispar  group,  three  main  subgroups  were  detected:  the  first 
(subgroup D-I) includes the reference strain SAW760; the second group includes only isolates from 
Asian  countries,  particularly  from  Iran  (subgroup  D-II);  the  third  group  (subgroup  D-III)  includes 
several strains from the same geographic region. All of the analyzed sequences were obtained from 
stool  samples.  The  three  sequences  obtained  from  samples  of  liver  abscesses  were  included  in 
subgroup  D-I  (patients  A-69,  A-104  and  N-77),  whereas  the  ICB-ADO  strain  showed  a  close 
relationship with the genealogy of subgroup D-II. With respect to the E. histolytica group, there were 
two  major  subgroups:  the  first  included  most  of  the  strains  of  E.  histolytica  reported  previously, 
including the reference strain HM1:IMSS (subgroup E-I), and the second subgroup (subgroup E-II) 
included strains isolated from animals [24] as well as the species E. nutalli (also of animal origin). The 
sequences obtained from our samples of liver abscesses were included in subgroup E-I (A-69, A-92 
and  A104).  These  sequences  had  a  close  phylogenetic  relationship  to  the  reference  strain  of  Int. J. Environ. Res. Public Health 2010, 7                 
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E. histolytica HM1:IMSS. Although strains of E. histolytica have been isolated in several geographical 
areas, they show very little variation with respect to the E. dispar group. 
Figure 1. Phylogenetic reconstruction through the neighbor-joining method from intergenic 
tRNA Dsp1-2 sequences of E. dispar and Hsp1-2 of E. histolytica. Bootstrap values with 
2500 replications are indicated close to the node numbers. Bar (0.02) shows nucleotide 
substitutions at each position. Colors in the first column indicate the source of samples and 
strain: Red, DNA of ALA; Blue, strains from fecal samples; Green, strains obtained in  
non-dysenteric amebic colitis; Yellow, animal source. The second column indicates the 
geographical region of the samples: Red, America; Blue, Asia; Green, Europe; White, data 
not available. 
   
 
To analyze the phylogenetic relationships of the ICB-ADO strain, four different molecular markers 
in addition to Dsp 1-2 were amplified and sequenced to resolve its taxonomic position. The results of 
each of the phylogenetic reconstructions, which included sequences of E. histolytica, E. dispar and  Int. J. Environ. Res. Public Health 2010, 7                 
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E. nutalli, demonstrate congruence between them. The ICB-ADO strain always appeared in the same 
group as  the reference strain of E. dispar SAW760 (Figure 2). The SQD3-5 markers and Dsp5-6 
(Figure 2A and  2B) showed no differences in the sequence between the ICB-ADO and E. dispar 
SAW760 strains. Based exclusively on these molecular markers, these results suggest that both strains 
belong  to  the  same  phylotype.  With  NKD3-5  and  StgaD3-5  markers,  however,  these  two  strains 
appeared in two different outer branches (Figure 2C and 2D). Based on these reconstructions, the  
ICB-ADO strain could be a genetic variant of the species E. dispar. In addition, DNA of the liver 
abscesses from patient A-104, amplified with the NKD3-5 primer, generating a PCR product that, once 
sequenced, also clustered in the same clade of E. dispar species. Based on these markers, is clear that 
the ICB-ADO strain and A-104 sample are variants of the species E. dispar.  
 
2.3. Genetic Diversity 
 
The  genetic  diversity  of  E.  dispar  and  E.  histolytica  analyzed  using  the  Dsp1-2  and  Hsp1-2 
molecular marker (250 bp) showed a high genetic diversity in the E. dispar group. This was in contrast 
with the diversity observed in the E. histolytica group. The numbers of haplotypes detected in samples 
of  ALA  from  the  E.  dispar  group  (Table  2)  showed  high  diversity  compared  to  the  ALA  of  the  
E. histolytic group. 
Although we have to mention that in the case of E. histolytica and E. dispar species, there is not an 
antecedent of the genetic diversity measured by the segregating sites and the rates of π and θ, values of 
genetic diversity observed in the two groups constructed with E. dispar sequences can be considered 
high, in accordance with previous reports where the number of haplotypes was estimated [10,11,25] 
(Table 2). In the group that included only liver abscess samples analyzed in this study, using four 
sequences we obtained three haplotypes, 33 segregating sites and values of π and θ of 0.065 and 0.071, 
respectively. When the analysis was performed with all the sequences registered in GenBank of the  
E. dispar group, we obtained 15 different haplotypes from 19 sequences, with 53 total segregating sites 
(Table  2).  In  the  two  groups  with  E.  histolytica,  we  found  that  for  the  group  that  included  only 
sequences of amebic liver abscesses, the genetic diversity was very low, showing only two haplotypes 
of  three  different  sequences  and  only  one  segregating  site.  The  diversity  of  the  total  sample  of  
E. histolytica available in GenBank data base was very different from that found in E. dispar; in this 
case, we only detected 7 haplotypes of 17 sequences with 49 segregating sites and a very low π value 
with respect to θ. The relationships between these two indexes indicate that the diversity in this group 
is  due  to  only  a  few  sequences  that  have  nearly  all  the  segregating  sites.  Comparing  the  genetic 
diversity of these two species in the group of patients with liver abscesses, it can be observed that  
E. dispar displays a high genetic diversity in relation to group of E. histolytica (Table 2). 
A number of studies have demonstrated the high genetic diversity of E. dispar and E. histolyica as 
well  as  the  evolutionary  dynamics  of  these  two  species  [10,26].  In  a  study  conducted  by  
Mojarad et al. [27], it was shown that the number of different genotypes of E. dispar isolated from 
asymptomatic cyst  passers  was  very high. In 28 isolates 12 new genotypes were found, a finding 
consistent with in E. dipar isolates from asymptomatic cyst passers in Mexico [12]. In the present 
work,  the  E.  dispar  detected  for  the  first  time  in  cases  of  liver  abscesses  were  also  found  to  be  
highly polymorphic.  Int. J. Environ. Res. Public Health 2010, 7                 
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2.4. Hypothetical Considerations to Explain the Presence of E. dispar in Amebic Abscess of the Liver  
 
The presence of DNA sequences of E. dispar in drainage samples of amebic liver abscesses in 
humans leads us to consider four different hypothetical scenarios. The first is based on a primary 
condition, that is, the necessary intestinal co-infection of the patient by a highly virulent E. histolytica 
and E. dispar species. Both species colonize the intestinal mucosa, and the invasive strain of the E. 
histolytica species displays all the known pathogenic strategies to induce the tissue damage of the 
intestinal epithelium. The E. histolytica trophozoites produce the ulceration of deeper intestinal tissue 
that  may  allow  trophozoites  to  reach  the  blood  capillary  network  and  then  migrate  to  the  portal 
circulatory system. Both E. histolytica and E. dispar trophozoites could then be seeded into the hepatic 
parenchyma. This scenario considers that E. dispar is moving by portal circulation into the liver with 
no  active  involvement  in  intestinal  tissue  damage. Once  E. dispar trophozoites  are in  the hepatic 
parenchyma  they  take  advantage  of  the  environment  created  by  E.  histolytica  trophozoites.  It  is 
possible that the initial density of the E. dispar population in the liver may be very low in relation to 
that  of  E.  histolytica,  and  E.  dispar  survival  in  this  environment  may  depend  on  the  damage 
presumably caused by E. histolytica (Figure 3A).  
The second hypothesis proposes that in the human host, under particular circumstances, E. dispar 
and E. histolytica are indeed pathogenic in both the colonic mucosa and the liver parenchyma. The 
dynamics of the infection indicate that the two species produce epithelial damage in the intestinal 
lumen and that both can migrate to and invade the liver, which presents with the known tissue damage 
done by both parasites. Under this hypothesis, the population densities of both species (in the intestine 
or  the  liver)  may  depend  on  their  particular  degree  of  virulence.  In  a  study  conducted  by  
Costa et al. [17], it was mention that two isolates of the species E. dispar obtained from Brazilian 
patients can induce amebic liver abscesses in experimental animals [17,27]. Their results showed that 
both of the tested isolates (ICB-ADO and MGL) can produce similar cytopathic effects and amebic 
liver abscesses compared to those produced by a highly virulent E. histolytica EGG strain [17]. 
On the other hand, in vitro and in vivo experimental models have suggested the potential pathogenic 
behavior of E. dispar, indicating that this species can produce damage to the intestinal or hepatic 
organs.  Nevertheless,  both  species  can  display  pathogenic  and  non-pathogenic  behaviors  under 
particular circumstances. The outcome of the host-parasite relationship in the human amebiasis may 
therefore  result  in  an  asymptomatic  infection  (asymptomatic  cysts  passers)  or  an  invasive  disease 
(intestinal amebiasis, amebic liver abscess) [18-21]. 
The third hypothetical scenario proposes that E. dispar could maintain symbiotic associations with 
bacteria from the intestinal flora, considering that the type of intestinal flora may enable or enhance the 
infectivity of E. dispar in either the intestinal lumen or the liver. Recent studies have demonstrated that 
isolates of E. dispar and E. histolytica in xenic or monoxenic culture conditions can increase their 
virulence,  causing  larger  liver  abscesses  in  laboratory  animals  in  comparison  to  E.  histolytica 
maintained in axenic culture conditions [17,27].  
In  endemic  areas  of  amebiasis,  the  co-infection  with  other  intestinal  pathogens  (bacteria  or 
parasites)  is  more  a  rule  rather  than  an  exception.  With  this  in  mind,  it  is  highly  possible  that 
interactions of Entamoeba species with both bacteria of intestinal flora [17,27-29] and/or pathogenic 
bacteria, may modify the infectious behavior of both (i.e., the parasite and the enterobacteria). Some Int. J. Environ. Res. Public Health 2010, 7                 
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pathogenic  enterobacteria  have  genes  that  encode  for  molecules  associated  directly  (pathogenicity 
island) [30,31] or indirectly (induction of inflammatory responses) [32,33] with tissue damage in the 
intestine  or  extraintestinal  organs,  such  as  the  liver.  Under  these  circumstances,  it  is  likely  that  
E.  dispar  and  E.  histolytica,  both  excellent  phagocytes  organisms,  may  ingest  bacteria  or  attach 
bacteria  to  their  membrane  surface  and  allow  the  expression  of  Entamoeba  or  bacteria  virulence 
molecules.  This  would  lead  to  simultaneous  tissue  damage  or  functional  alterations.  The  possible 
molecular  mechanisms  to  explain  this  circumstance  can  be  the  lateral  transference  of  pathogenic 
enterobacteria genes to Entamoeba species, or the induction of expression or overexpression of both 
bacteria and/or Entamoeba pathogenic genes. We have to mention that bacterial lateral gene transfer 
particularly in E. histolytica species, has been previously reported [34-36]. On the other hand, the 
induction or increase in virulence of E. histolytica HM1:IMSS mediated by the presence of pathogenic 
enterobacteria has been recently described in full detail by Galvan-Moroyoki et al. (2008) [37]. They 
showed that the effect of Shigella dysenteriae and Escherichia coli (EPEC) increased the cytopathic 
effect on epithelial cells, cysteine proteinase activity and the expression of Gal/GalNac lectin on the  
E. histolytica membrane surface and that these effects are enhanced when E. histolytica phagocytosed 
bacteria. One of their relevant findings was the interplay between bacteria-epithelial cells, which made 
the epithelial  cells  more susceptible to  damage from  E. histolytica. This in particular induced the 
expression  of  the  pro-inflammatory  interleukin  IL-8,  which  is  chemiotactic  for  neutrophils  and  
E. histolytica trophozoites. In contrast, under the same conditions, the E. dispar SAW760 strain was 
not affected and did not display any pathogenic behavior. The authors suggest that the infection with 
pathogen enterobacteria may prepare the intestinal epithelial cells, making them susceptible to the 
mechanism of virulence displayed by E. histolytica. The evidence of the pathogenicity of the E. dispar 
ICB-ADO strain isolated from a patient with a clinical diagnosis of non-dysenteric amebic colitis, and 
tested in in vitro studies and through the induction of amebic liver abscesses in the hamster model, 
displays a variety of the pathogenic effects observed in the E. histolytica infection. As we already 
mentioned, the E. dispar ICB-ADO strain used in our experiments was maintained in a xenic culture 
containing the original intestinal flora. This culture was previously tested for the induction of amebic 
liver abscesses, including the simultaneous induction of the abscess with virulent axenic trofozoites of 
E. histolytica HM1:IMSS as a positive control. In contrast, the induction of liver abscesses with the 
bacterial flora and without trophozoites did not produce hepatic damage [17].  
We  must  describe  the  differences  between  our  results  and  those  reported  by  
Galvan-Moroyoqui et al. [37], particularly in relation to the failure to induce pathogenic behavior in 
the E. dispar SAW760 mediated by S. dysenteriae and Escherichia coli (EPEC). As mentioned, the 
ICB-ADO strain was isolated from a patient of non-dysenteric amebic colitis maintained in a xenic 
culture containing the patient’s original intestinal flora. In contrast, E. dispar SAW760 was isolated 
from  an  asymptomatic  cyst  passer,  and  the  strain  was  maintained  under  axenic  conditions. 
Furthermore, the cytopathic studies carried out with the ICB-ADO strain showed a positive cytopathic 
effect on epithelial cell monolayers and on the induction of amebic liver abscesses in hamsters. In 
addition, the assays utilizing another Brazilian isolate from an asymptomatic patient (MGL) maintained 
under xenic conditions also induced amebic liver abscesses. This strain was characterized as E. dispar 
zymodem 1 [17,27]. Moreover, in the presence of Crithidia fasciculate, both the ICB-ADO and MGL 
strains  failed  to  produce  amebic  liver  abscesses  under  monoxenic  conditions  in  the  hamster  Int. J. Environ. Res. Public Health 2010, 7                 
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model  [17,27].  The  evidence  described  above  support  the  participation  of  intestinal  bacteria, 
pathogenic or not, in the induction or modulation of the virulent phenotype of the Entamoeba species. 
Are  these  conditions  fundamentally  important  in  the  expression  of  a  pathogenic  phenotype  in  the 
Entamoeba species in humans? This is a question to be addressed in the near future. Nevertheless, it 
should be noted that clinically, three of the six patients were diagnosed with pyogenic liver abscesses 
and  one  as  a  mixed  liver  abscess.  Only  two  patients  were  clinically  diagnosed  with  amebic  liver 
abscesses. However, the characteristic of the drained material correlated with the purulent material 
used for clinical diagnosis; unfortunately, the bacteriological study and it results were unavailable. 
Even though, these data are particularly suggestive of a participation of bacteria in tissue damage, we 
have to acknowledge that, our results are related with DNA sequences of intergenic regions associated 
to  tRNA  of  Entamoeba  species,  not  bacterial  genes,  which  do  not  prove  or  disapprove  the  
proposed scenario.  
The fourth hypothesis is indeed supported by results of the estimation of genetic diversity (Table 2), 
suggesting  that  E.  histolytica  infection  may  be  a  clonal  infection  while  E.  dispar  is  considerably 
diverse, which point out to possible recombination events between Entamoeba species. If we consider 
that  the  genetic  limits  between  both  E.  histolytica  and  E.  dispar  species  are  tenuous  and  the 
hybridization  phenomena  possible,  we  should  be  able  to  find  some  of  pathogenic  factors  of  E. 
histolytica in the genetic background of E. dispar, this is not a minor subject , if we take into account 
that several of the pathogenic genes detected in E. histolytica are also present in E. dispar, at least in 
the reference strains E. histolytica HM1:IMSS and E. dispar SAW760, besides, these strains are only 
two more strains in the vast and diverse Entamoeba species population.  
Table 1. Clinical data of patients with liver abscesses that were PCR-positive for molecular 
markers Hsp1-2. and/or Dsp1-2 It is noted that abscesses clinically diagnosed as pyogenic 
were PCR positive for E. dispar species. 
Sample Code  CD
1  Gender  Age  ELISA
2  PCR-MD
3 
A-69  MLA  F  57  0.63  E.h, E.d 
A-92  ALA  F  39  1.1  E.h, E.d 
A-104  ALA  M  40  1.1  E.h, E.d 
N-49  PLA  F  52  0.14  E.d 
N-61  PLA  F  38  0.47  E.d 
N-77  PLA  M  55  0.27  E.d 
1 Clinical diagnosis: MLA, mixed liver abscess (amebic and pyogenic); ALA, amebic liver abscess; 
PLA, pyogenic liver abscess. 
2 Levels of IgG anti-amebic antibodies, values represent the O.D. at 490 nm. Cut off value 0.52. 
3 Molecular diagnosis: E.h, Entamoeba histolytica; E.d, Entamoeba dispar. Int. J. Environ. Res. Public Health 2010, 7                 
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Table 2. Parameters related to the genetic diversity of four different groups of the species 
E.  dispar  and E. histolytica using Dsp1-2 and Hsp1-2 molecular markers (250 bp). In 
contrast to the E. histolytica group, there was high genetic diversity in the E. dispar group. 
The number of haplotypes detected in samples of amebic liver abscess (ALA) of the E. 
dispar group showed a high diversity compared to the ALA of the E. histolytic group. 
Group
1  No. Sequences  No. Haplotypes  Ss
2   
E. dispar ALA  4  3  33  0.065  0.071 
E. dispar total  19  15  53  0.081  0.064 
E. histolytica ALA  3  2  1  0.002  0.002 
E. histolytica total  17  7  49  0.034  0.069 
1E. dispar ALA and E. histolytica ALA: Number of samples of liver abscesses obtained in this 
study;  E.  dispar  total  and  E.  histolytica  total:  number  of  analyzed  sequences  available  in  the 
GeneBank data base
 
2Number of segregated sites. 
Figure 2. Four phylogenetic reconstructions of intergenic tRNA sequences of E. dispar, E. 
histolytica and ICB-ADO strains (A, SQD3-5; B, Dsp5-6; C, StgaD3-5; and D, NKD3-5) 
performed through the neighbor-joining method. Bootstraps values with 2500 replications 
are indicated close to the node numbers. The ICB-ADO strain is included in the E. dispar 
group in all phylogenies. 
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Figure  3.  Four  different  hypotheses  may  explain  the  presence  of  E.  dispar  in  liver 
abscesses.  First,  E.  histolytica  (blue)  species  invade  the  intestinal  mucosa,  producing 
erosion and ulceration of intestinal tissue. Both species are then placed in portal circulation 
and seeded into the liver. E. dispar (red) does not produce tissue damage but may take 
advantage of the pathogenic capacity of the E. histolytica species (1). The second possible 
explanation proposes that the two species are similarly responsible of both the intestinal 
and liver damage (2). The third hypothesis deals with bacteria-mediated pathogenicity. This 
suggests that the pathogenesis of at least some E. dispar strains may be mediated by (Black 
points) a type of bacterial flora in a particular host (3). The fourth hypothesis (Table 2) 
suggest that recombination events between E. histolytica and E. dispar species. In the right 
column are included the samples that could represent the possible hypothetical scenarios.  
 
 
3. Experimental Section  
 
3.1. DNA Extraction and Molecular Markers (Targets)  
 
With the purpose of cleaning the sample and removing mucus from the liver abscess drainage,  
200−500 μL of the sample were placed in 500 μL of MgSO4 0.1 M. Thereafter, 50 μL l of proteinase K 
was added and incubated at 56 º C for 30 min. DNA was then extracted using the “DNA Easy Tissue” 
Kit (Qiagen, Valencia, CA, USA) following the manufacturer’s instructions. DNA from the ICB-ADO Int. J. Environ. Res. Public Health 2010, 7                 
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strain was obtained from 10
6 trophozoites harvested from a xenic culture using the TRIZOL reagent kit 
(Invitrogen, Life Technology, Carlsbad, CA, USA) following the manufacturer’s instructions.  
Five  different  tRNA  gene-linked  short tandem  repeats  were amplified in  both  DNA from  liver 
abscess  drainage  and  from  trophozoites  of  the  ICB-ADO  strain  using  primers  species-specific  for  
E. dispar and E. histolytica as previously described [38]. Dsp1-2 and Hsp1-2 locus from different liver 
abscesses were amplified using Dsp1 and Dsp2 for E. dispar and Hsp1 and Hsp2 for E. histolytica. The 
reaction and conditions for Dsp1-2 and Hsp1-2 loci was identical. A total volume of 20 µL reaction 
was prepared with 1 U of Taq polymerase (Roche: Diagnostics Gmbh Mannheim, Germany), 5.0 mM 
of MgCl2, 1 mM of dNTP, 2 µM of each primer and 2 µL of DNA 25−100 ng/µL. The PCR conditions 
were as follows: 5 min at 95 ° C for the initial incubation, followed by 30 cycles of 30 sec at 95 ° C,  
30 s at 55 ° C and 30 s at 72 ° C and a final extension step of 10 min at 72 ° C. To obtain a greater 
quantity of PCR product, we made a re-amplification under the same conditions using 1 μL of the 
amplified product. Dsp1-2 and Hsp1-2 PCR products size are 430 pb and 340 pb respectively. The 
PCR re-amplification product was purified using the “Gel Extraction DNA kit (Qiagen Valencia, CA, 
USA). The selected bands (the same size of the E. dispar SAW760 and E. histolytica HM1:IMSS) 
were cut and sequenced with the same primers used in PCR amplification. 
The other molecular markers were used to amplify only DNA of the ICB-ADO strain using both 
species-specific primers for E. dispar (Dsp5-6, SQD3-5, StgaD3-5 and NKD3-5) and E. histolytica 
(Hsp5-6, SQH3-5, StgaH3-5 and NKH3-5). The reaction and PCR conditions for amplification of these 
molecular targets was previously described [38].  
 
3.2. Phylogenetic Reconstruction for Different Molecular Markers 
 
The sequencing reactions had a total volume of 15 µL consisting of 2 µL of the Big Dye Terminator 
Sequencing kit (Applied Biosystems), 1.6 µM of primer and 5 µL of the purified amplified product. 
The amplification conditions were: 1 cycle of 5 min at 95 ° C, 45 cycles of 10 s at 95 ° C, 10 s at  
50 ° C and 4 min at 60 ° C. Sequencing was done in a capillary sequencer (ABI-Avant 100). 
Sequences  were  manually  verified  with  the  BioEdit  program  [39].  Taxonomic  identity  was 
established by comparing the obtained sequences against the GenBank (NCBI) data. Sequences were 
aligned using the ClustalX software program [40]. Phylogenetic reconstruction for molecular markers 
Dsp1-2 and Hsp1-2, Dsp5-6, SQ, Stga and NK was carried out through the neighbor-joining method 
using the MEGA program, version 3.0 [41]. The substitution model for each one of the markers was 
Kimura 2-P.  
 
3.3. Population Genetics Analysis 
 
Through the use of sequences of Dsp1-2 and Hsp1-2, different parameters of population genetics 
were analyzed. We made four different groups for diversity genetics analysis: sequences of E. dispar 
obtained from liver abscesses analyzed in the present study, all sequences of the species E. dispar 
available in GenBank data base, sequences of E. histolytica obtained from liver abscesses in this study 
and the total sample of sequences from E. histolytica accessed in GenBank. The number of segregant Int. J. Environ. Res. Public Health 2010, 7                 
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sites, the number of haplotypes per group, the mean nucleotide diversity per site (π) and the expected 
variation per site under the neutral evolution assumption (θ) were obtained using DnaSP version 5.0 [42].  
 
3.4. Nucleotide Sequence Accession Numbers 
 
The  partial  sequences  of  the  different  samples  of  liver  abscesses  and  the  ICB-ADO  strain 
determined  in  this  study  have  been  deposited  in  GenBank  under  accession  numbers  GU324326  
to GU324337.  
 
4. Conclusions  
 
The present results undoubtedly demonstrate the existence of different genotypes of the E. dispar 
species that can reach the liver during an invasive amebiasis event. Whether this Entamoeba species is 
playing an active role in the hepatic tissue damage observed in amebic liver abscesses or if it is only a 
passive  participant  in  the  described  damage  needs  to  be  determined  systematically.  The  evidence 
presented here is not simply anecdotic, as our data indicate; the phenomenon is real and more frequent 
than previously assumed. In our opinion, this is not a circumstance restricted to Mexico. It is likely that 
this phenomenon can also be observed in other endemic areas. 
The proposed hypothetical scenarios are not merely speculative and can be reasonable approached; 
some studies have demonstrated that the third hypotheses may explain the presence of E. dispar in liver 
abscesses of patients studied in this work [27]. On the other hand, by utilizing molecular sequencing 
techniques and using five different molecular markers, it was shown that the ICB-ADO strain, which is 
responsible for the intestinal damage in the colon of the studied patient and later tested in laboratory 
animals, is a genotype of the species E. dispar. Hypothesis 2 and 4 are indeed supported by the present 
results (Table 2). These scenarios are not contradictory and can be almost simultaneously approached.  
Finally, the high genetic diversity found in both samples of genotypes from liver abscesses as the 
total  sample  of  E.  dispar  (Table  2)  suggests  that  recombination,  genetic  differentiation  and/or 
differential  selection  processes  may  be  operating  in  this  species.  Further  analysis  to  estimate  the 
frequency of this event in other patients with liver abscesses is required to determine the dynamics of 
infection  and  co-infection  by  Entamoeba  and  the  interaction  with  bacterial  flora  and/or  bacterial 
pathogens in endemic areas of amebiasis. As mentioned, it should be noted that co-infections due to 
intestinal parasites and gastrointestinal bacterial pathogens are the rule and not the exception. It is clear 
that the key approach to a rational control of this health problem is multidisciplinary epidemiological 
research. Are we at the beginning of a change in the paradigm regarding to the pathogenicity of both 
Entamoeba species? In this sense, there is sufficient evidence to consider E. dispar as a potential agent 
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